AF
CTSO icon

Amalgamated Financial’s Cytosorbents Corp CTSO Stock Holding History

Amalgamated Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$21K Buy
+6,733
New +$24.1K ﹤0.01% 2732

Other funds holding CTSO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Amalgamated Financial's CTSO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Cytosorbents Corp (CTSO) in Q1 2022: 6,733 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #2732 among its holdings.

88 funds tracked by Wall St. Rank hold CTSO as of Q1 2022.

  • Amalgamated Financial held 6,733 shares of Cytosorbents Corp worth $21K as of Q1 2022.
  • Cytosorbents Corp was a new Amalgamated Financial position in Q1 2022.
  • Cytosorbents Corp made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2732 holding.
  • 88 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.